Original investigation
Published: 2017-09-15

Quality of life in patients with mild dementia. Validation of the Italian version of the quality of life Alzheimer’s disease (QoL-AD) Scale

Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy
Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy
Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy
Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy
Quality of life Dementia Assessment

Abstract

Background and aims: to investigate possible clinical determinants of quality of life (QoL) in mild dementia
Methods: 200 dementia outpatients assessed with the Quality of Life-AD (QoL-AD) scale administered to patients
and their caregivers and combined into a QoL-AD composite score (QoL-AD CS). Patients were divided
into tertiles according to high, intermediate and low QoL levels. Cognitive status was assessed with the Mini
Mental State Examination (MMSE) and depressive symptoms with the Geriatric Depression Scale (GDS). Basic
(BADL) and instrumental (IADL) activities of daily living scales were used to assess functional domain. The
Neuropsychiatric Inventory (NPI) measured neuropsychiatric symptoms.
Results: a strong correlation was found between patient-rated QoL-AD scores and caregiver-rated QoL-AD
scores (Pearson correlation coefficient: .353; p = .000). High QoL group patients displayed better functional
status in BADL and IADL, had lower comorbidity and number of medications. Insight level and cognition were
comparable among the three groups. The group with higher QoL had significantly lower depressive and neuropsychiatric
symptoms compared to the intermediate and low QoL groups. On linear regression analysis using
the QoL-AD CS as the depended variable, the model including GDS, IADL, number of medications and NPI
explains nearly 50% of QoL-CS variance (R2 = .495; adjusted R2 = .485).
Conclusions: QoL in mild dementia is a broad dominion that goes beyond the cognitive impairment itself
and is determined by for the presence of depression, impairment in instrumental activities of daily living, behavioural
disturbances and number of medications.

Affiliations

A. Bianchetti

Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy

C. Cornali

Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy

P. Ranieri

Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy

M. Trabucchi

Department of Medicine and Rehabilitation, Istituto Clinico S. Anna Hospital Brescia and Geriatric Research Group, Brescia, Italy

Copyright

© Società Italiana di Gerontologia e Geriatria (SIGG) , 2017

How to Cite

[1]
Bianchetti, A., Cornali, C., Ranieri, P. and Trabucchi, M. 2017. Quality of life in patients with mild dementia. Validation of the Italian version of the quality of life Alzheimer’s disease (QoL-AD) Scale. JOURNAL OF GERONTOLOGY AND GERIATRICS. 65, 3 (Sep. 2017), 137-143.
  • Abstract viewed - 2 times
  • PDF downloaded - 1 times